Advertisement

Current Rheumatology Reports

, Volume 11, Issue 2, pp 154–160 | Cite as

Quality of life and quality of care for patients with gout

  • Jasvinder A. SinghEmail author
Article

Abstract

Significant pain, activity limitation, and disability in patients with acute and chronic gouty arthritis lower health-related quality of life. Although many effective therapies are available for gouty arthritis, medication errors are common. One goal of therapy is to reduce the frequency of gout flares by lowering serum uric acid. Further, evidence suggests that the quality of care provided to patients with gout may also impact health-related quality of life. This article reviews evidence concerning quality of care and quality of life for patients with gout.

Keywords

Colchicine Gout Allopurinol Serum Uric Acid Uric Acid Level 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Kramer HM, Curhan G: The association between gout and nephrolithiasis: the national health and nutrition examination survey iii, 1988–1994. Am J Kidney Dis 2002, 40:37–42.PubMedCrossRefGoogle Scholar
  2. 2.
    Kim KY, Ralph Schumacher H, Hunsche E, et al.: A literature review of the epidemiology and treatment of acute gout. Clin Ther 2003, 25:1593–1617.PubMedCrossRefGoogle Scholar
  3. 3.
    Krishnan E, Griffith C, Kwoh K: Burden of illness from gout in ambulatory care in the United States. Arthritis Rheum 2005, 52:S656.Google Scholar
  4. 4.
    Mikuls TR, MacLean CH, Olivieri J, et al.: Quality of care indicators for gout management. Arthritis Rheum 2004, 50:937–943.PubMedCrossRefGoogle Scholar
  5. 5.
    Emmerson BT: The management of gout. N Engl J Med 1996, 334:445–451.PubMedCrossRefGoogle Scholar
  6. 6.
    Terkeltaub RA: Clinical practice. Gout. N Engl J Med 2003, 349:1647–1655.PubMedCrossRefGoogle Scholar
  7. 7.
    Perez-Ruiz F, Lioté F: Lowering serum uric acid levels: what is the optimal target for improving clinical outcomes in gout? Arthritis Rheum 2007, 57:1324–1328.PubMedCrossRefGoogle Scholar
  8. 8.
    Chin MH, Wang LC, Jin L, et al.: Appropriateness of medication selection for older persons in an urban academic emergency department. Acad Emerg Med 1999, 6:1232–1242.PubMedCrossRefGoogle Scholar
  9. 9.
    Smith P, Karlson N, Nair BR: Quality use of allopurinol in the elderly. J Qual Clin Pract 2000, 20:42–43.PubMedCrossRefGoogle Scholar
  10. 10.
    Mikuls TR, Curtis JR, Allison JJ, et al.: Medication errors with the use of allopurinol and colchicine: a retrospective study of a national, anonymous internet-accessible error reporting system. J Rheumatol 2006, 33:562–566.PubMedGoogle Scholar
  11. 11.
    Ly J, Gow P, Dalbeth N: Colchicine prescribing and safety monitoring in patients with gout. N Z Med J 2007, 120:U2808.PubMedGoogle Scholar
  12. 12.
    Dalbeth N, Kumar S, Stamp L, Gow P: Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout. J Rheumatol 2006, 33:1646–1650.PubMedGoogle Scholar
  13. 13.
    Singh JA, Hodges JM, Asch SM: Opportunities for improving medication use and monitoring in gout. Ann Rheum Dis 2009 (in press).Google Scholar
  14. 14.
    Sarawate CA, Brewer KK, Yang W, et al.: Gout medication treatment patterns and adherence to standards of care from a managed care perspective. Mayo Clin Proc 2006, 81:925–934.PubMedCrossRefGoogle Scholar
  15. 15.
    Roddy E, Zhang W, Doherty M: Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations. Ann Rheum Dis 2007, 66:1311–1315.PubMedCrossRefGoogle Scholar
  16. 16.
    Pal B, Foxall M, Dysart T, et al.: How is gout managed in primary care? A review of current practice and proposed guidelines. Clin Rheumatol 2000, 19:21–25.PubMedCrossRefGoogle Scholar
  17. 17.
    Neogi T, Hunter DJ, Chaisson CE, et al.: Frequency and predictors of inappropriate management of recurrent gout attacks in a longitudinal study. J Rheumatol 2006, 33:104–109.PubMedGoogle Scholar
  18. 18.
    Mikuls TR, Farrar JT, Bilker WB, et al.: Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK general practice research database (GPRD). Rheumatology (Oxford) 2005, 44:1038–1042.CrossRefGoogle Scholar
  19. 19.
    Singh JA, Hodges JS, Toscano JP, Asch SM: Quality of care for gout in the US needs improvement. Arthritis Rheum 2007, 57:822–829.PubMedCrossRefGoogle Scholar
  20. 20.
    McGlynn EA, Asch SM, Adams J, et al.: The quality of health care delivered to adults in the United States. N Engl J Med 2003, 348:2635–2645.PubMedCrossRefGoogle Scholar
  21. 21.
    Asch SM, McGlynn EA, Hogan MM, et al.: Comparison of quality of care for patients in the veterans health administration and patients in a national sample. Ann Intern Med 2004, 141:938–945.PubMedGoogle Scholar
  22. 22.
    Owens D, Whelan B, McCarthy G: A survey of the management of gout in primary care. Ir Med J 2008, 101:147–149.PubMedGoogle Scholar
  23. 23.
    Roberts C, Adebajo AO, Long S: Improving the quality of care of musculoskeletal conditions in primary care. Rheumatology (Oxford) 2002, 41:503–508.CrossRefGoogle Scholar
  24. 24.
    Fang W, Zeng X, Li M, et al.: The management of gout at an academic healthcare center in Beijing: A physician survey. J Rheumatol 2006, 33:2041–2049.PubMedGoogle Scholar
  25. 25.
    Roddy E, Zhang W, Doherty M: Is gout associated with reduced quality of life? A case-control study. Rheumatology (Oxford) 2007, 46:1441–1444.CrossRefGoogle Scholar
  26. 26.
    Singh JA, Strand V: Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans. Ann Rheum Dis 2008, 67:1310–1316.PubMedCrossRefGoogle Scholar
  27. 27.
    Hirsch JD, Lee SJ, Terkeltaub R, et al.: Evaluation of an instrument assessing influence of gout on health-related quality of life. J Rheumatol 2008, 35:2406–2414.PubMedCrossRefGoogle Scholar
  28. 28.
    Khanna D, Ahmed M, Yontz D, et al.: The disutility of chronic gout. Qual Life Res 2008, 17:815–822.PubMedCrossRefGoogle Scholar

Copyright information

© Current Medicine Group, LLC 2009

Authors and Affiliations

  1. 1.Rheumatology Section, Medicine ServiceVA Medical CenterMinneapolisUSA

Personalised recommendations